121 related articles for article (PubMed ID: 36323547)
1. [Clinicopathological characteristics of PAX5 positive anaplastic large cell lymphoma with extra copies of the PAX5 gene locus].
Chen YP; Ni ML; Ke LF; Zhang WW; Qiu YT; Wang JC; Zhu Q; Chen G
Zhonghua Bing Li Xue Za Zhi; 2022 Nov; 51(11):1155-1157. PubMed ID: 36323547
[No Abstract] [Full Text] [Related]
2. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.
Feldman AL; Law ME; Inwards DJ; Dogan A; McClure RF; Macon WR
Mod Pathol; 2010 Apr; 23(4):593-602. PubMed ID: 20118907
[TBL] [Abstract][Full Text] [Related]
3. ALK-negative anaplastic large cell lymphoma with "Hodgkin-like" cytomorphology and nuclear expression of PAX5.
Fratoni S; Niscola P; Zhao XF; Larocca LM; Capalbo A; Fabbretti M; Bernardini L; Abruzzese E
Pathol Res Pract; 2020 Feb; 216(2):152724. PubMed ID: 31784094
[TBL] [Abstract][Full Text] [Related]
4. Refractory case of ALK-negative anaplastic large-cell lymphoma with PAX-5 expression and T-cell receptor-γ gene rearrangement.
Kawakami K; Yazaki A; Ito R; Tono Y; Murata T; Baba Y; Uchiyama T; Imai H; Nakamura S
J Clin Exp Hematop; 2013; 53(3):251-4. PubMed ID: 24369229
[No Abstract] [Full Text] [Related]
5. ALK-negative anaplastic large cell lymphoma, null type with aberrant expression of PAX5 and CD138: A diagnostic pitfall.
Salyana MA; Khan S; Zhang X
Diagn Cytopathol; 2021 Oct; 49(10):E395-E399. PubMed ID: 34190415
[TBL] [Abstract][Full Text] [Related]
6. CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL).
Ranuhardy D; Suzanna E; Sari RM; Hadisantoso DW; Andalucia R; Abdillah A
Acta Med Indones; 2018 Apr; 50(2):104-109. PubMed ID: 29950528
[TBL] [Abstract][Full Text] [Related]
7. PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.
Arun I; Roy P; Arora N; Bhave SJ; Nair R; Chandy M
Int J Surg Pathol; 2017 Jun; 25(4):333-338. PubMed ID: 28013563
[TBL] [Abstract][Full Text] [Related]
8. PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvement.
Ong DM; Cummins KD; Pham A; Grigoriadis G
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26187868
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
10. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Wang X; Boddicker RL; Dasari S; Sidhu JS; Kadin ME; Macon WR; Ansell SM; Ketterling RP; Rech KL; Feldman AL
Hum Pathol; 2017 Jun; 64():19-27. PubMed ID: 28153507
[TBL] [Abstract][Full Text] [Related]
11. Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas.
Yu R; Chen G; Zhou C; Gao Z; Shi Y; Shi Y; Zhou X; Xie J; Liu H; Gong L
Leuk Res; 2012 Sep; 36(9):1141-6. PubMed ID: 22726922
[TBL] [Abstract][Full Text] [Related]
12. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
[TBL] [Abstract][Full Text] [Related]
13. [Effect of pax5 gene blocked by RNAi on biological characteristics of B cell malignant lymphoma].
Yuan XL; Zhang B; Jiang LM; Shen LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):799-803. PubMed ID: 18718064
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement.
Khanlari M; Tang G; Hao S; Gong Y; Li S; Miranda RN; Lin P; Iyer S; Yin CC; Xie W; Vega F; Medeiros LJ; Xu J
Br J Haematol; 2021 Jan; 192(1):e17-e21. PubMed ID: 33216956
[No Abstract] [Full Text] [Related]
15. PAX5 haploinsufficiency induce cancer cell dormancy in Raji cells.
Liang X; Gu J; Li T; Zhao L; Fu X; Zhang W; Wang J; Shang Z; Huang W; Zhou J
Exp Cell Res; 2018 Jun; 367(1):30-36. PubMed ID: 29453973
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
17. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance].
Jing CX; Feng Y; Cao X; Xu CG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142
[TBL] [Abstract][Full Text] [Related]
18. Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.
Bharti B; Shukla S; Tripathi R; Mishra S; Kumar M; Pandey M; Mishra R
Indian J Med Res; 2016 May; 143(Supplement):S23-S31. PubMed ID: 27748274
[TBL] [Abstract][Full Text] [Related]
19. Germline PAX5 mutations and B cell leukemia.
Hyde RK; Liu PP
Nat Genet; 2013 Oct; 45(10):1104-5. PubMed ID: 24071841
[TBL] [Abstract][Full Text] [Related]
20. β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Anand M; Lai R; Gelebart P
Haematologica; 2011 Feb; 96(2):253-61. PubMed ID: 20971814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
